PROPANC BIOPHARMA, INC.
302, 6 Butler Street
Camberwell, VIC, 3124 Australia
|June 20, 2019|
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Attention: Sonia Bednarowski
|Re:||Propanc Biopharma, Inc.|
|Registration Statement on Form S-1 (the “Registration Statement”)|
|File No. 333-231682|
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Propanc Biopharma, Inc. hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that it will become effective at 12:00 P.M. Eastern Daylight Time on Friday, June 21, 2019, or as soon as practicable thereafter.
We respectfully request that we be notified of such effectiveness by a telephone call to Sasha Ablovatskiy, Esq. of Foley Shechter Ablovatskiy LLP at (212) 335-0466, or in his absence Jonathan Shechter, Esq. of Foley Shechter Ablovatskiy LLP at (212) 335-0465.
|PROPANC BIOPHARMA, INC.|
|By:||/s/ James Nathanielsz|
|Title:||Chief Executive Officer|
|Cc:||Jonathan Shechter, Esq. of Foley Shechter Ablovatskiy LLP|
|Sasha Ablovatskiy, Esq. of Foley Shechter Ablovatskiy LLP|